Abstract
This chapter examines referral patterns to a dedicated secondary care neurology-led cognitive disorders clinic in terms of numbers seen over the period 2002–2013, sources (primary and secondary care), patient age, and casemix in terms of diagnosis. Although referrals have increased, the proportion of dementia diagnoses has not changed, indicating the persistence of a dementia diagnosis gap.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Association of British Neurologists. Acute neurological emergencies in adults. London: Association of British Neurologists; 2002.
Audit Commission. Forget me not. Developing mental health services for older people in England. London: Audit Commission; 2002.
Borson S, Scanlan J, Brush M, Vitaliano P, Dokmak A. The mini-cog: a cognitive “vital signs” measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 2000;15:1021–7.
Brodaty H, Pond D, Kemp NM, et al. The GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc. 2002;50:530–4.
Brodaty H, Low-Lee F, Gibson L, Burns K. What is the best dementia screening instrument for general practitioners to use? Am J Geriatr Psychiatry. 2006;14:391–400.
Brooke P, Bullock R. Validation of a 6 item Cognitive Impairment Test with a view to primary care usage. Int J Geriatr Psychiatry. 1999;14:936–40.
Cagliarini AM, Price HL, Livemore ST, Larner AJ. Will use of the Six-Item Cognitive Impairment Test help to close the dementia diagnosis gap? Aging Health. 2013;9:563–6.
Davies RR, Doran M, Larner AJ. Early-onset dementia. Prog Neurol Psychiatry. 2011;15(4):12–6.
Department of Health. Living well with dementia: a National Dementia Strategy. London: Department of Health; 2009.
Department of Health/Alzheimer’s Society. Understanding dementia. A resource pack for GPs and patients. London: Alzheimer’s Society; 2009.
Doran M. Diagnosis of presenile dementia. Br J Hosp Med. 1997;58:105–10.
Fearn S, Larner AJ. Quality and Outcomes Framework Depression Indicators. Ment Health Fam Med. 2009;6:129–32.
Ferran J, Wilson K, Doran M, Ghadiali E, Johnson F, Cooper P, McCracken C. The early onset dementias: a study of clinical characteristics and service use. Int J Geriatr Psychiatry. 1996;11:863–9.
Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112–7.
Fisher CAH, Larner AJ. FAQs: memory loss. Practitioner. 2006;250(1683):14–6, 19, 21.
Fisher CAH, Larner AJ. Frequency and diagnostic utility of cognitive test instrument use by general practitioners prior to memory clinic referral. Fam Pract. 2007;24:495–7.
Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
Ghadiri-Sani M, Larner AJ. Cognitive screening instrument use in primary care: is it changing? J Neurol Neurosurg Psychiatry. 2014; abstract accepted.
Hodkinson HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing. 1972;1:233–8.
Hussey D, Foy K, Meehean K. Quality of dementia referrals to later life psychiatry service. Psychiatr Bull. 2009;33:154–5.
Larner AJ. Two simple questions in the identification of dementia. J Neurol Neurosurg Psychiatry. 2005a;76:1317 (abstract 023).
Larner AJ. An audit of the Addenbrooke’s Cognitive Examination (ACE) in clinical practice. Int J Geriatr Psychiatry. 2005b;20:593–4.
Larner AJ. Neurologists still have a role in the dementia care pathway. Clin Med. 2007a;7:528–9.
Larner AJ. Addenbrooke’s Cognitive Examination (ACE) for the diagnosis and differential diagnosis of dementia. Clin Neurol Neurosurg. 2007b;109:491–4.
Larner AJ. Neuropsychological neurology: the neurocognitive impairments of neurological disorders. Cambridge: Cambridge University Press; 2008.
Larner AJ. Impact of the National Institute for Health and Clinical Excellence and Social Care Institute for Excellence’s dementia guidelines in a neurology-led memory clinic. Clin Med. 2009a;9:197–8.
Larner AJ. Quality of dementia referrals. Psychiatr Bull. 2009b;33:316.
Larner AJ. ACE-R: cross-sectional and longitudinal use for cognitive assessment. In: Fisher A, Hanin I, editors. New trends in Alzheimer and Parkinson related disorders: ADPD 2009. Collection of selected free papers from the 9th international conference on Alzheimer’s and Parkinson’s disease AD/PD, Prague, 11–15 Mar 2009. Bologna: Medimond International Proceedings; 2009c. p. 103–7.
Larner AJ. Impact of the National Dementia Strategy in a neurology-led memory clinic. Clin Med. 2010;10:526.
Larner AJ. Screening utility of the Montreal Cognitive Assessment (MoCA): in place of – or as well as – the MMSE? Int Psychogeriatr. 2012;24:391–6.
Larner AJ. Conclusion: place of cognitive screening instruments: test characteristics and suspected diagnosis. In: Larner AJ, editor. Cognitive screening instruments. A practical approach. London: Springer; 2013a. p. 219–38.
Larner AJ. Neuropsychological neurology: the neurocognitive impairments of neurological disorders. 2nd ed. Cambridge: Cambridge University Press; 2013b.
Larner AJ. Addenbrooke’s Cognitive Examination-Revised (ACE-R): pragmatic study of cross-sectional use for assessment of cognitive complaints of unknown aetiology. Int J Geriatr Psychiatry. 2013c;28:547–8.
Larner AJ. Impact of the National Dementia Strategy in a neurology-led memory clinic: 5-year data. Clin Med. 2014;14:in press.
Larner AJ, Coles AJ, Scolding NJ, Barker RA. The A-Z of neurological practice. A guide to clinical neurology. 2nd ed. London: Springer; 2011.
Meeuwsen EJ, Melis RJF, Van Der Aa GCHM, et al. Effectiveness of dementia follow-up care by memory clinics of general practitioners: randomised controlled trial. BMJ. 2012;344:e3086.
Menon R, Larner AJ. Use of cognitive screening instruments in primary care: the impact of national dementia directives (NICE/SCIE, National Dementia Strategy). Fam Pract. 2011;28:272–6.
Milne A, Culverwell A, Guss R, Tuppen J, Whelton R. Screening for dementia in primary care: a review of the use, efficacy and quality of measures. Int Psychogeriatr. 2008;20:911–26.
National Institute for Health and Clinical Excellence/Social Care Institute for Excellence. Dementia: supporting people with dementia and their carers in health and social care. NICE Clinical Guidance 42. London: National Institute for Health and Clinical Excellence (www.nice.org.uk/cG042); 2006.
O’Connor DW, Pollitt BA, Hyde JB, et al. Do general practitioners miss dementia in elderly patients? BMJ. 1988;297:1107–10.
Price HL, Larner AJ. Type 2 diabetes and cognitive impairment: a case for screening? Prog Neurol Psychiatry. 2013;17(5):6–7.
Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD. The diagnosis of young-onset dementia. Lancet Neurol. 2010;9:793–806.
Wimo A, Prince M. World Alzheimer Report 2010. The global economic impact of dementia. London: Alzheimer’s Disease International; 2010.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London Limited
About this chapter
Cite this chapter
Larner, A.J. (2014). Referral Patterns. In: Dementia in Clinical Practice: A Neurological Perspective. Springer, London. https://doi.org/10.1007/978-1-4471-6371-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-4471-6371-8_1
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-6370-1
Online ISBN: 978-1-4471-6371-8
eBook Packages: MedicineMedicine (R0)